IQWiG rebuffs Shire's Elvanse

Germany's Institute for Quality and Efficiency in Healthcare (IQWiG) said ADHD drug Elvanse lisdexamfetamine dimesylate from Shire plc (LSE:SHP; NASDAQ:SHPG) has "no additional benefit" over Strattera...